A Descriptive Review on Nanosponges in Novel Drug Delivery, Synthetic Methods, Advantages and Applications
DOI:
https://doi.org/10.37285/ijpsn.2023.16.4.10Abstract
Nanosponges are the newest and one of the most versatile carriers synthesized employing nanotechnology and miniaturization, which have been a blessing to the field of novel drug delivery. Nanosponges (NSs) are a class of hyper cross-linked three-dimensional colloidal architectures responsible for dramatically increasing the solubilization potential of poorly soluble drugs and an array of advantages. They are synthesized using a biocompatible polymer and a cross-linker in a specified ratio and comprise a cavity which can engulf lipophilic or hydrophilic drug molecules. An elaborate literature review stresses the various synthetic methods adopted for synthesizing nanosponges, promising applications and advantages of nanosponges in novel drug delivery with some patented work in this domain. Challenging molecules such as lipophilic drug molecules, nutraceuticals, gases, proteins and peptides, volatile oils, genetic material, etc., can be loaded on these novel carriers, which are spherical, porous, versatile, stable, compact, convenient to synthesize and easy to scale-up in the laboratory. This descriptive review stresses the explanation of the synthetic methods of nanosponges in addition to the advantages and applications of cyclodextrin-based NS in novel drug delivery. These supramolecular entities offer a high degree of drug loading compared to other nanocarriers and, thus, are of prominent interest to research scientists globally. Additionally, nanosponge formulations like parenteral, topical, oral or inhalation continue to portray significant utility and scope in the novel drug delivery arena and depict remarkable future and growth potential. Therefore, owing to their convenient method of synthesis, propitious advantages and prominent applications in modern-day drug delivery, the review's authors hope that helpful information and insight about this novel carrier reaches the researchers and scientists and help them better understand nanosponges.
Downloads
Metrics
Keywords:
Nanosponges, Cyclodextrin, Nanocarrier, Novel, Bioavailability, Solubility Enhancement
Downloads
Published
How to Cite
Issue
Section
References
Abass MM, Rajab NA. Preparation and characterization of etodolac as a topical nanosponges hydrogel. Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512). 2019 Jun 11;28(1):64-74.
Aberoumandi SM, Mohammadhosseini M, Abasi E, Saghati S, Nikzamir N, Akbarzadeh A, Panahi Y, Davaran S. An update on applications of nanostructured drug delivery systems in cancer therapy: a review. Artificial cells, nanomedicine, and biotechnology. 2017 Aug 18;45(6):1058-68.
Acosta E. Bioavailability of nanoparticles in nutrient and nutraceutical delivery. Current opinion in colloid & interface science. 2009 Feb 1;14(1):3-15.
Ahmed RZ, Patil G, Zaheer Z. Nanosponges–a completely new nano-horizon: pharmaceutical applications and recent advances. Drug development and industrial pharmacy. 2013 Sep 1;39(9):1263-72.
Avila-Olias M, Pegoraro C, Battaglia G, Canton I. Inspired by nature: fundamentals in nanotechnology design to overcome biological barriers. Therapeutic delivery. 2013 Jan;4(1):27-43.
Bamrungsap S, Zhao Z, Chen T, Wang L, Li C, Fu T, Tan W. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine. 2012 Aug;7(8):1253-71.
Bhatia S, Bhatia S. Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications. Natural Polymer Drug Delivery Systems: Nanoparticles, Plants, and Algae. 2016:33-93.
Shringirishi M, Prajapati SK, Mahor A, Alok S, Yadav P, Verma A. Nanosponges: a potential nanocarrier for novel drug delivery-a review. Asian pacific journal of tropical disease. 2014 Sep 1;4:S519-26.
Trotta F, Dianzani C, Caldera F, Mognetti B, Cavalli R. The application of nanosponges to cancer drug delivery. Expert Opinion on Drug Delivery. 2014 Jun 1;11(6):931-41.
Selvamuthukumar S, Anandam S, Krishnamoorthy K, Rajappan M. Nanosponges: A novel class of drug delivery system-review. Journal of Pharmacy & Pharmaceutical Sciences. 2012 Jan 17;15(1):103-11.
Pushpalatha R, Selvamuthukumar S, Kilimozhi D. Hierarchy analysis of different cross-linkers used for the preparation of cross-linked cyclodextrin as drug nanocarriers. Chemical Engineering Communications. 2018 Jun 3;205(6):759-71.
Venuti V, Rossi B, Mele A, Melone L, Punta C, Majolino D, Masciovecchio C, Caldera F, Trotta F. Tuning structural parameters for the optimization of drug delivery performance of cyclodextrin-based nanosponges. Expert Opinion on Drug Delivery. 2017 Mar 4;14(3):331-40.
Trotta F, Zanetti M, Cavalli R. Cyclodextrin-based nanosponges as drug carriers. Beilstein journal of organic chemistry. 2012 Nov 29;8(1):2091-9.
Chilajwar SV, Pednekar PP, Jadhav KR, Gupta GJ, Kadam VJ. Cyclodextrin-based nanosponges: A propitious platform for enhancing drug delivery. Expert opinion on drug delivery. 2014 Jan 1;11(1):111-20.
Pawar S, Shende P. A comprehensive patent review on β-cyclodextrin cross-linked nanosponges for multiple applications. Recent Patents on Nanotechnology. 2020 Mar 1;14(1):75-89.
Wadhwa A, Mathura V, Lewis SA. Emerging novel nanopharmaceuticals for drug delivery. Asian J Pharm Clin Res. 2018 Jul 1;11(7):35-42.
Rajam RP, Muthukumar KR. An updated comprehensive review on nanosponges-novel emerging drug delivery system. Research Journal of Pharmacy and Technology. 2021;14(8):4476-84.
Conceicao J, Adeoye O, Cabral-Marques HM, Lobo J. Cyclodextrins as drug carriers in pharmaceutical technology: the state of the art. Current pharmaceutical design. 2018 Apr 1;24(13):1405-33.
Sherje AP, Dravyakar BR, Kadam D, Jadhav M. Cyclodextrin-based nanosponges: A critical review. Carbohydrate polymers. 2017 Oct 1;173:37-49.
Swaminathan S, Vavia PR, Trotta F, Cavalli R, Tumbiolo S, Bertinetti L, Coluccia S. Structural evidence of differential forms of nanosponges of beta-cyclodextrin and its effect on solubilization of a model drug. Journal of inclusion phenomena and macrocyclic chemistry. 2013 Jun;76:201-11.
Tannous M, Caldera F, Hoti G, Dianzani U, Cavalli R, Trotta F. Drug-encapsulated cyclodextrin nanosponges. Supramolecules in Drug Discovery and Drug Delivery: Methods and Protocols. 2021:247-83.
Tejashri G, Amrita B, Darshana J. Cyclodextrin based nanosponges for pharmaceutical use: A review. Acta pharmaceutica. 2013 Sep 30;63(3):335-58.
Shivani S, Poladi KK. Nanosponges-novel emerging drug delivery system: A review. International journal of pharmaceutical sciences and research. 2015 Feb 1;6(2):529.
Mishra M, Kumar P, Rajawat JS, Malik R, Sharma G, Modgil A. Nanotechnology: Revolutionizing the science of drug delivery. Current pharmaceutical design. 2018 Dec 1;24(43):5086-107.
Mura P. Analytical techniques for characterization of cyclodextrin complexes in the solid state: A review. Journal of pharmaceutical and biomedical analysis. 2015 Sep 10;113:226-38.
Osmani AM, R Bhosale R, Hani U, Vaghela R, K Kulkarni P. Cyclodextrin based nanosponges: impending carters in drug delivery and nanotherapeutics. Current Drug Therapy. 2015 Apr 1;10(1):3-19.
Osmani AM, Hani U, R Bhosale R, K Kulkarni P, Shanmuganathan S. Nanosponge carriers-an archetype swing in cancer therapy: a comprehensive review. Current drug targets. 2017 Jan 1;18(1):108-18.
Pandey P, Dureja H. Recent patents on polymeric nanoparticles for cancer therapy. Recent Patents on Nanotechnology. 2018 Aug 1;12(2):155-69.
Pandey P, Purohit D, Dureja H. Nanosponges–A promising novel drug delivery system. Recent patents on nanotechnology. 2018 Dec 1;12(3):180-91.
Patil TS, Nalawade NA, Kakade VK, Kale SN. Nanosponges: A novel targeted drug delivery for cancer treatment. International Journal for Advance Research and Development. 2017;2(4).
Indira B, Bolisetti SS, Samrat C, Reddy SM, Reddy NS. Nanosponges: a new era in drug delivery. Journal of pharmacy research. 2012;5(12):5293-6.
A Ansari K, J Torne S, Vavia PR, Trotta F, Cavalli R. Paclitaxel loaded nanosponges: in-vitro characterization and cytotoxicity study on MCF-7 cell line culture. Current drug delivery. 2011 Mar 1;8(2):194-202.
Swaminathan S, Pastero L, Serpe L, Trotta F, Vavia P, Aquilano D, Trotta M, Zara G, Cavalli R. Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity. European Journal of Pharmaceutics and Biopharmaceutics. 2010 Feb 1;74(2):193-201.
Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug discovery today. 2003 Dec 15;8(24):1112-20.
Allahyari S, Esmailnezhad N, Valizadeh H, Ghorbani M, Jelvehgari M, Ghazi F, Zakeri-Milani P. In-vitro characterization and cytotoxicity study of flutamide loaded cyclodextrin nanosponges. Journal of Drug Delivery Science and Technology. 2021 Feb 1;61:102275.
Cai Z, Wang Y, Zhu LJ, Liu ZQ. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs. Current Drug Metabolism. 2010 Feb 1;11(2):197-207.
Penjuri SC, Ravouru N, Damineni S, Bns S, Poreddy SR. Formulation and evaluation of lansoprazole loaded Nanosponges. Turk. J. Pharm. Sci. 2016 Sep 1;13(3):304-10.
Kamble M, Zaheer Z, Mokale S, Zainuddin R. Formulation optimization and biopharmaceutical evaluation of imatinib mesylate loaded β-cyclodextrin nanosponges. Pharmaceutical Nanotechnology. 2019 Dec 1;7(5):343-61.
Hayiyana Z, E Choonara Y, Makgotloe A, C du Toit L, Kumar P, Pillay V. Ester-based hydrophilic cyclodextrin nanosponges for topical ocular drug delivery. Current pharmaceutical design. 2016 Dec 1;22(46):6988-97.
Rao MR, Bhingole RC. Nanosponge-based pediatric-controlled release dry suspension of Gabapentin for reconstitution. Drug development and industrial pharmacy. 2015 Dec 2;41(12):2029-36.
Anandam S, Selvamuthukumar S. Fabrication of cyclodextrin nanosponges for quercetin delivery: physicochemical characterization, photostability, and antioxidant effects. Journal of materials science. 2014 Dec;49:8140-53.
Hariri G, Edwards AD, Merrill TB, Greenbaum JM, van der Ende AE, Harth E. Sequential targeted delivery of paclitaxel and camptothecin using a cross-linked “nanosponge” network for lung cancer chemotherapy. Molecular pharmaceutics. 2014 Jan 6;11(1):265-75.
Swaminathan S, Vavia PR, Trotta F, Torne S. Formulation of betacyclodextrin based nanosponges of Itraconazole. Journal of inclusion phenomena and macrocyclic chemistry. 2007 Apr;57:89-94.
Srinivas P, Jahnavi Reddy A. Formulation and evaluation of isoniazid loaded nanosponges for topical delivery. Pharmaceutical Nanotechnology. 2015 Mar 1;3(1):68-76.
Swaminathan S, Cavalli R, Trotta F, Ferruti P, Ranucci E, Gerges I, Manfredi A, Marinotto D, Vavia PR. In vitro release modulation and conformational stabilization of a model protein using swellable polyamidoamine nanosponges of β-cyclodextrin. Journal of inclusion phenomena and macrocyclic chemistry. 2010 Oct;68:183-91.
Lembo D, Swaminathan S, Donalisio M, Civra A, Pastero L, Aquilano D, Vavia P, Trotta F, Cavalli R. Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy. International journal of pharmaceutics. 2013 Feb 25;443(1-2):262-72.
Ansari KA, Vavia PR, Trotta F, Cavalli R. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterization, stability, cytotoxicity and permeation study. Aaps Pharmscitech. 2011 Mar;12:279-86.
Darandale SS, Vavia PR. Cyclodextrin-based nanosponges of curcumin: formulation and physicochemical characterization. Journal of inclusion phenomena and macrocyclic chemistry. 2013 Apr;75:315-22.
Farooq MA, Aquib M, Farooq A, Haleem Khan D, Joelle Maviah MB, Sied Filli M, Kesse S, Boakye-Yiadom KO, Mavlyanova R, Parveen A, Wang B. Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview. Artificial cells, nanomedicine, and biotechnology. 2019 Dec 4;47(1):1674-92.
Wang TY, Kendrick-Williams LL, Choy MY, Gilmore KA, Bonnard T, Pearce HA, Law LS, Carmichael I, Cody SH, Alt K, Hagemeyer CE. Collagen-targeted theranostic nanosponges for delivery of the matrix metalloproteinase 14 inhibitor naphthofluorescein. Chemistry of Materials. 2020 Apr 14;32(9):3707-14.
Cavalli R, Akhter AK, Bisazza A, Giustetto P, Trotta F, Vavia P. Nanosponge formulations as oxygen delivery systems. International journal of pharmaceutics. 2010 Dec 15;402(1-2):254-7.
Boscolo B, Trotta F, Ghibaudi E. High catalytic performances of Pseudomonas fluorescens lipase adsorbed on a new type of cyclodextrin-based nanosponges. Journal of Molecular Catalysis B: Enzymatic. 2010 Feb 1;62(2):155-61.
Trotta F, Tumiatti V, Cavalli R, Rogero C, Mognetti B, Berta G. Cyclodextrin-based nanosponges as a vehicle for antitumoral drugs. WO 3656:A1, 2009.
Wingnien Wylie O, Tinlok LI, Zhijian Lin. Cross-linked nanoporous saccharide-based material and methods for fabrication thereof. WO2020011197A1, 2020.
Gilardi G, Di Nardo G, Trotta F, Tumiatti V, Cavalli R, Ferruti P. Cyclodextrin nanosponges as a carrier for biocatalysts, and in the delivery and release of enzymes, proteins, vaccines and antibodies. WO2009149883A1, 2008.
Trotta F, Caldera F. Cross-linked starch-based polymers for drug-delivery. WO2019202148A1, 2018.
Trotta F, Tumiatti W, Cavalli R. Nanosponges based on cyclodextrins functionalized with carboxyl groups in the synthesis and use decontamination from heavy metals and organic compounds by chromatographic separations and drug delivery. ITMI20040614A1, 2004.
Wingnien Wylie O, Tinlok LI, Zhijian Lin. Cross-linked nanoporous saccharide-based material and methods for fabrication thereof. WO2020011197A1, 2020.
Won Il Choi, Tae Gi Yoong. Heparin nanosponge for controlled release of growth factors and method for manufacturing thereof. KR101920284B1, 2017.
Choi Won LI, Lee Jin Sil. Injectable thermosponge nanoparticle-based hydrogel and its use. KR20190122368A, 2019.
Choi WI. Thermosponge nanoparticle platform for simultaneous delivery of hydrophilic and hydrophobic drugs, and use thereof. WO2019182278A1, 2018.
Ferruti P, Ranucci E, Trotta F. Hyperbranched polymers based on cyclodextrins and poly (amidoamines) for the controlled release of insoluble drugs. US Patent US8372933B2, 2008.
